Policy & Regulation
UPS Subsidiary Marken Expands Coverage and Product Portfolio
12 February 2018 - - Research Triangle Park, North Carolina-based clinical trial logistics and supply chain services company Marken has expanded its geographic reach and product portfolio in 2017, the company said.
Increased demand for depot, depot-related drug distribution, and patient-centric services continues to inspire investment in infrastructure, pharmaceutical expertise and project management capability.
In 2017, the company expanded its market coverage from 148 to 155 countries countries, and added more than 120 new pharmaceutical, manufacturing, and clinical research clients.
Additionaly, Marken doubled the volume of work in its ten GMP-certified depots, tripled the volume of direct-to-patient (DTO) shipments, and expanded DTP into 50 countries.
The company also opened a new headquarters in Research Triangle Park, North Carolina and expanded its facility footprint to 47 locations.
Marken, a wholly owned subsidiary of UPS, is dedicated to the pharmaceutical and life sciences industries.
The company's more than 800 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 220 countries.
Additional services include biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy.